DK0808154T3 - Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer - Google Patents

Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer

Info

Publication number
DK0808154T3
DK0808154T3 DK96904552T DK96904552T DK0808154T3 DK 0808154 T3 DK0808154 T3 DK 0808154T3 DK 96904552 T DK96904552 T DK 96904552T DK 96904552 T DK96904552 T DK 96904552T DK 0808154 T3 DK0808154 T3 DK 0808154T3
Authority
DK
Denmark
Prior art keywords
formulations
compounds
fatty acids
nanoparticle dispersions
digestible oils
Prior art date
Application number
DK96904552T
Other languages
Danish (da)
English (en)
Inventor
W Mark Eickhoff
Karl R Mueller
David A Engers
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/384,057 external-priority patent/US5571536A/en
Priority claimed from US08/388,088 external-priority patent/US5560931A/en
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Application granted granted Critical
Publication of DK0808154T3 publication Critical patent/DK0808154T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96904552T 1995-02-06 1996-01-31 Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer DK0808154T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/384,057 US5571536A (en) 1995-02-06 1995-02-06 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US08/388,088 US5560931A (en) 1995-02-14 1995-02-14 Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
PCT/US1996/001433 WO1996024332A1 (fr) 1995-02-06 1996-01-31 Formulations de composes se presentant sous forme de dispersions nanoparticulaires dans des huiles ou des acides gras digestibles

Publications (1)

Publication Number Publication Date
DK0808154T3 true DK0808154T3 (da) 2001-04-30

Family

ID=27010448

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96904552T DK0808154T3 (da) 1995-02-06 1996-01-31 Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer

Country Status (11)

Country Link
EP (1) EP0808154B1 (fr)
JP (1) JPH10513200A (fr)
AT (1) ATE198148T1 (fr)
AU (1) AU4862796A (fr)
CA (1) CA2207304A1 (fr)
DE (1) DE69611287T2 (fr)
DK (1) DK0808154T3 (fr)
ES (1) ES2154806T3 (fr)
GR (1) GR3035613T3 (fr)
PT (1) PT808154E (fr)
WO (1) WO1996024332A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
JP4709378B2 (ja) * 1998-03-30 2011-06-22 オバン・エナジー・リミテッド 水不溶性物質のマイクロ粒子を製造するための組成物及び方法
US6337092B1 (en) 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
WO2010079037A2 (fr) * 2008-12-18 2010-07-15 Basf Se Dispersion aqueuse contenant des particules de pesticides et un amphiphile

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9022788D0 (en) * 1990-10-19 1990-12-05 Cortecs Ltd Pharmaceutical formulations
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions

Also Published As

Publication number Publication date
CA2207304A1 (fr) 1996-08-15
EP0808154B1 (fr) 2000-12-20
DE69611287D1 (de) 2001-01-25
ES2154806T3 (es) 2001-04-16
EP0808154A1 (fr) 1997-11-26
PT808154E (pt) 2001-06-29
DE69611287T2 (de) 2001-08-09
ATE198148T1 (de) 2001-01-15
JPH10513200A (ja) 1998-12-15
AU4862796A (en) 1996-08-27
WO1996024332A1 (fr) 1996-08-15
GR3035613T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
US6191121B1 (en) Treatment of skin damage using polyenylphosphatidylcholine
DK0808154T3 (da) Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer
KR20010006022A (ko) 아스코르브산을 함유하는 안정한 국소용 향장품/약제용 에멀션 조성물
BR9800890A (pt) Microemulsão
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
EP0406162A3 (en) Process for the preparation of a nanoemulsion of oilparticles in an aqueous phase
DE3579069D1 (de) Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung.
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
ATE207346T1 (de) Orale pharmazeutische zusammensetzungen mit sexualhormonen
EP1072246A3 (fr) Compositions cosmétiques et dermatologiques basées sur des émulsions huile-dans-eau
DE69900345T2 (de) Nanoemulsion aus Fettsäureestern von Phosphorsäure und deren Verwendung in Kosmetika, Dermatologie, Pharmazeutika und/oder Ophthalmologie
KR940018091A (ko) 불포화 지방산을 포함하는 처방
DE69900328T2 (de) Nanoemulsion aus Fettsäureestern von Glycerin und deren Verwendungen in Kosmetika, Dermatologie und/oder Ophthalmologie
EP1072249A3 (fr) Compositions cosmétiques et dermatologiques basées sur des émulsions huile-dans-eau
EP1072247A3 (fr) Compositions cosmétiques et dermatologiques basées sur des émulsions huile-dans-eau
ATE101036T1 (de) Aktivitaetspotenziator gegen krebs.
JPH09309813A (ja) 皮膚外用剤
KR850002230A (ko) 생체유효도가 증강된 비타민 조성물
GEP20033046B (en) Parenteral Cisplatin Emulsion
PT938339E (pt) Formulacoes para utilizacao topica
WO1999039682A3 (fr) Melanges lipidiques et leur utilisation
JP2005008591A (ja) 乳化・可溶化皮膚外用剤
JPH0717860A (ja) 脂溶性物質含有液剤および脂溶性物質の乳化・可溶化方法
PT1005275E (pt) Formulacao inibidora e profilactica
GB2362105A (en) Aciclovir compositions containing dimethicone